Stockscreener 앱 받기
1.62
2.53%
0.04
시장 영업 전:
1.61
-0.01
-0.62%
전일 마감가:
$1.58
열려 있는:
$1.61
하루 거래량:
108.87K
Relative Volume:
1.24
시가총액:
$2.31M
수익:
-
순이익/손실:
$-7.98M
주가수익비율:
-0.1847
EPS:
-8.7693
순현금흐름:
$-6.49M
1주 성능:
-1.82%
1개월 성능:
-17.35%
6개월 성능:
-83.22%
1년 성능:
-91.12%
1일 변동 폭
$1.59
$1.6999
1주일 범위
$1.54
$1.6999
52주 변동 폭
$1.54
$30.25
Adial Pharmaceuticals Inc Stock (ADIL) Company Profile
명칭
Adial Pharmaceuticals Inc
전화
434-422-9800
주소
1180 SEMINOLE TRAIL, CHARLOTTESVILLE, VA
Compare ADIL vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADIL
Adial Pharmaceuticals Inc
|
1.62 | 2.26M | 0 | -7.98M | -6.49M | -8.7693 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 112.35B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.71B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 52.29B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 44.48B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 35.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Adial Pharmaceuticals Inc Stock (ADIL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-14 | 개시 | Rodman & Renshaw | Buy |
| 2018-10-30 | 개시 | Maxim Group | Buy |
| 2018-10-11 | 개시 | Dawson James | Buy |
Adial Pharmaceuticals Inc 주식(ADIL)의 최신 뉴스
Adial Pharmaceuticals lead drug fits new policy mood as bipartisan bill signals broader lens on alcohol use disorder - MSN
ADIL Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Published on: 2026-04-10 14:04:42 - baoquankhu1.vn
Adial Pharmaceuticals Files 8-K on Executive Changes and Restricted Stock Award Agreement - Minichart
Adial Pharmaceuticals Implements New Executive Equity Compensation Plan - TipRanks
Adial Pharmaceuticals grants restricted stock awards to Cary Claiborne, Vinay Shah and Tony Goodman - TradingView
[Form 4] ADIAL PHARMACEUTICALS, INC. Insider Trading Activity - Stock Titan
Adial Pharmaceuticals (ADIL) director receives 9,185 stock options at $1.64 strike - Stock Titan
Adial (NASDAQ: ADIL) awards RSAs and stock options to board members - Stock Titan
Director at Adial (NASDAQ: ADIL) receives 9,185 restricted shares - Stock Titan
Adial Pharmaceuticals (ADIL) CFO receives 17,325-share restricted stock grant - Stock Titan
ADIAL (ADIL) director awarded 9,185 restricted shares in equity grant - Stock Titan
Adial Pharmaceuticals (NASDAQ: ADIL) CEO granted 37,985 shares - Stock Titan
Investor Mood: Will Adial Pharmaceuticals Inc benefit from government policy2026 Selloffs & AI Enhanced Trading Signals - baoquankhu1.vn
Hedge Fund Bets: Whats the MACD signal for Adial Pharmaceuticals Inc2026 Dividend Review & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Market Moves: Whats Adial Pharmaceuticals Incs historical returnDollar Strength & Daily Stock Trend Reports - baoquankhu1.vn
Aug Closing: Does Adial Pharmaceuticals Inc offer margin of safetyStock Surge & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Valuation Update: Will Adial Pharmaceuticals Inc benefit from geopolitical trends2026 Review & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Adial Pharmaceuticals Lead Drug Fits New Policy Mood As Bipartisan Bill Signals Broader Lens On Alcohol Use Disorder - Sahm
Adial Pharmaceuticals Commends Introduction of H.R. 7091 to Expand Access to Alcohol Use Disorder Treatments for Veterans - Quiver Quantitative
Adial Pharmaceuticals Commends Congress on Introduction of - GlobeNewswire
Adial Pharmaceuticals Commends Congress on Introduction of Bipartisan Legislation Expanding Access to Emerging AUD Therapies for Veterans - The Manila Times
Smart Money: Does Adial Pharmaceuticals Inc have a competitive edge2026 Trade Ideas & Daily Stock Trend Reports - baoquankhu1.vn
Nasdaq Moves: Whats the beta of Adial Pharmaceuticals Inc stock2026 Analyst Calls & Real-Time Volume Analysis - baoquankhu1.vn
Revenue per share of Adial Pharmaceuticals, Inc – NASDAQ:ADIL - TradingView
Tech Rally: Whats the fair value of Adial Pharmaceuticals Inc stockPortfolio Risk Summary & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Is Adial Pharmaceuticals Inc. stock a smart buy before Fed meetingPortfolio Return Report & High Conviction Investment Ideas - Naître et grandir
Key facts: Adial Pharmaceuticals reports $7.98M annual loss; 2025 results show regulatory progress - TradingView
Adial Pharmaceuticals (ADIL) Enhances Financial Position and Cli - GuruFocus
Adial Pharmaceuticals Reports 2025 Fiscal Year Financial Results and Provides Business Update - TradingView
Adial Pharmaceuticals (NASDAQ: ADIL) outlines AD04 advances, Europe deal and Nasdaq win - Stock Titan
Adial Pharmaceuticals 10-K: $(7.98M) Net Loss, $(11.93) EPS; Cash into H2 2026 - TradingView
Adial Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
ADIL SEC FilingsAdial Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Adial Pharmaceuticals signs framework deal with Molteni for Europe By Investing.com - Investing.com Canada
Adial Pharmaceuticals (ADIL) Plans European Expansion for AD04 w - GuruFocus
Adial Pharmaceuticals signs exclusive AD04 collaboration framework with Molteni Farmaceutici for Europe - marketscreener.com
Adial Pharmaceuticals signs framework deal with Molteni for Europe - Investing.com
Adial Pharmaceuticals Secures European Partnership for AD04 Commercialization - TipRanks
Adial Pharmaceuticals enters exclusive AD04 Europe framework with Molteni; potential $60M in royalties & milestones - TradingView
Adial (NASDAQ: ADIL) outlines AD04 Europe deal framework with Molteni - Stock Titan
Adial Pharmaceuticals, Inc. Enters into A Collaboration Framework Agreement with Molteni Farmaceutici - marketscreener.com
EXCLUSIVE: Adial Pharma Eyes Europe Deal For Lead Drug For Alcohol Use Disrder Worth Up To $60 Million - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Adial Pharmaceuticals (ADIL) to Release Quarterly Earnings on Tuesday - Defense World
Adial Pharmaceuticals Highlights FDA Policy Direction That May Reduce Pivotal Trial Burden from Two Studies to One - ADVFN Ltd
Adial Pharmaceuticals, IncWarrant (NQ: ADILW - The Chronicle-Journal
Adial Pharmaceuticals Secures Exchange Listing Amid Regulatory Tailwinds - AD HOC NEWS
Short Interest in Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Decreases By 87.7% - Defense World
ADIL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Adial Pharmaceuticals Inc (ADIL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.69%
0.25%
자본화:
|
볼륨(24시간):